Grant number: IIRS-18-051 | Funding period: 2018 - 2021
Completed
T Kader, M Zethoven, S Mahale, H Saunders, L Tjoeka, R Lehmann, MW Jayawardana, JM Pang, D Lesche, N Rajan, T Semple, JEA Lee, R Lupat, DJ Byrne, S Hughes, H Nguyen, S Lai, M Pechlivanis, O Craig, L Devereux
2026-01-01
Development of ipsilateral breast carcinoma following a diagnosis of breast ductal carcinoma in situ (DCIS) has been assumed to re..
RI Udayasiri, T Luo, KL Gorringe, SB Fox
2023-01-01
Ductal carcinoma in situ (DCIS) of the breast is a non-invasive tumour that has the potential to progress to invasive ductal carci..
T Kader, M Zethoven, KL Gorringe
2022-12-01
Clonal analysis of tumour sequencing data enables the evaluation of the relationship of histologically distinct synchronous lesion..
MS Toss, A Abidi, D Lesche, C Joseph, S Mahale, H Saunders, T Kader, IM Miligy, AR Green, KL Gorringe, EA Rakha
2020-05-12
Background: The role of different subtypes of tumour infiltrating lymphocytes (TILs) in breast ductal carcinoma in situ (DCIS) is ..